| abstract |
The present invention provides compounds that are tyrosine kinase inhibitors, specifically Bruton's tyrosine kinase ("BTK") inhibitors, and are therefore useful in the treatment of diseases treatable by inhibition of BTK , such as cancer, autoimmune, inflammatory, and thromboembolic diseases. Also provided are pharmaceutical compositions containing such compounds and methods for preparing such compounds. |